Former Chief Financial Officer · INSMED Inc (INSM)

Paolo Tombesi

A named executive officer of INSMED in every fiscal year CompBrief holds from FY2017 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,527,332

Salary $189,958Stock awards $0

FY2018: $2,023,828

5th of 7 named executive officers at Insmed by FY2019 total.

7 named officers on file for INSMED, FY2019

Paolo Tombesi’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • INSM’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how INSMED’s whole pay program stands against its peers

  • INSMED’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on INSM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 31, 2020 (DEF 14A).

Free

Get Paolo Tombesi’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Paolo Tombesi compensation by year

INSMED Summary Compensation Table · all 3 fiscal years held
In US dollars, as INSMED reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019
Salary$253,750$442,620$189,958
Bonus$40,000$0$0
Stock awards$0$324,978$0
Option awards$1,300,046$975,001$974,990
Non-equity incentive$277,400$270,000$0
Pension and deferred compensation$0$0$0
All other$12,087$11,229$362,384
Total$1,883,283$2,023,828$1,527,332

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: INSMED Inc DEF 14A filed March 31, 2020, accession 0001047469-20-001933, and prior-year filings. Open the filing on EDGAR.

How this page was built: the INSMED Inc filed document, accession 0001047469-20-001933. Every figure is read from that document and cited to the page and table it appears in. Filed March 31, 2020.

$1.9M
$2.0M
$1.5M
FY17
FY18
FY19
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
RSU10,669$139,977—
Option55,400—$30.46
Option79,475—$15.60

Per the Outstanding Equity Awards at Fiscal Year-End table in INSMED Inc's FY2018 proxy; value at the fiscal year-end close, as the company printed it.

INSMED’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
William LewisPresident and CEO$7,175,094
Roger AdsettChief Operating Officer$3,728,403
Christine PellizzariFormer Chief Legal Officer$2,709,564
S. Nicole SchaefferChief People Strategy Officer$2,312,597
Paolo Tombesi · this pageFormer Chief Financial Officer$1,527,332
John GollFormer Principal Financial Officer$832,283
Martina FlammerChief Medical Officer$80,185

The full INSMED compensation record

free company brief

This page is one person within INSMED's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the INSMED proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are INSMED's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Paolo Tombesi's compensation dossier · One-time report. No refunds.